Antiplatelet agents reduce risk of postoperative IOL bleeding
The use of antiplatelet agents, such as aspirin and clopidogrel, are safer to use compared to anticoagulation (warfarin) therapy, according to the American Journal of Ophthalmology.
The use of antiplatelet agents, such as aspirin and clopidogrel, are safer to use compared to anticoagulation (warfarin) therapy, according to the American Journal of Ophthalmology.
Dr Jaeryung Oh et al., Department of Ophthalmology, Anam Hospital, Korea University College of Medicine, Seoul, Korea, conducted an observational, retrospective case control study on 822 patients who underwent vitreoretinal surgery in 1994, 2004 and 2008.
The outcome measures included the proportion using antiplatelets or anticoagulants, the occurrence of early postoperative intraocular bleeding in patients, and clinical outcomes of the haemorrhage.
The findings demonstrated that the rate of anticoagulant therapy didn't vary and lowers the risk of intraocular haemorrhage after vitrectomy.
AAO 2023: Company updates from Centricity Vision CEO Rob Thornhill
November 28th 2023At this year's American Academy of Ophthalmology meeting in San Francisco, California, Rob Thornhill, CEO of Centricity Vision, spoke with the Ophthalmology Times team about developments in the company's ZEPTOLink IOL positioning systems.
AAO 2023: Marco A. Zarbin, MD, PhD, provides analysis of the YOSEMITE and RHINE clinical trials
November 24th 2023At this year's American Academy of Ophthalmology meeting in San Francisco, California, Marco A. Zarbin, MD, spoke with Ophthalmology Times about his team's post-hoc analysis of the YOSEMITE and RHINE clinical trials
